Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cyclacel Pharmaceuti (CYCC)

1.71 -0.02 (-1.16%)

12-15 16:00

Open:

1.73

Pre. Close:

1.73

High:

1.74

Low:

1.691

Volume:

259,158

Market Cap:

20M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.79 - 1.85

1.85 - 1.89

Low:

1.6 - 1.64

1.64 - 1.68

Close:

1.65 - 1.73

1.73 - 1.8

Technical analysis  (as of: 2017-12-15 4:54:31 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.32     One year: 2.63

Support:

Support1: 1.57    Support2: 1.31

Resistance:

Resistance1: 1.99    Resistance2: 2.25

Pivot:

1.87

Moving Averages:

MA(5): 1.76     MA(20): 1.85

MA(100): 1.78     MA(250): 3.45

MACD:

MACD(12,26): -0.01     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 21.39     %D(3): 23.84

RSI:

RSI(14): 45.07

52-Week:

High: 10.9  Low: 1.5  Change(%): -57.9

Average Vol(K):

3-Month: 89559  10-Days 179125

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CYCC has closed above bottom band by 19.5%. Bollinger Bands are 1.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Dec 2017 20:37:30 GMT
What's In Store For Cyclacel Pharmaceuticals, Inc. (CYCC), Illumina, Inc. (ILMN)?

Wed, 13 Dec 2017 16:18:45 GMT
How Does Cyclacel Pharmaceuticals, Inc. (CYCC) Stack Up Right Now?

Mon, 11 Dec 2017 16:41:15 GMT
Today Analysts Focus on 22nd Century Group, Inc. (XXII), Cyclacel ...

Mon, 11 Dec 2017 11:48:45 GMT
Stock Review for Biotech's Investors -- Cyclacel Pharma, Capricor Therapeutics ...

Tue, 12 Dec 2017 14:26:15 GMT
Taking Tally Of Cyclacel Pharmaceuticals, Inc. (CYCC), Ekso Bionics Holdings ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

11.90

Shares Float (M)

9.59

% Held by Insiders

19.32

% Held by Institutions

6.88

Shares Short (K)

791

Shares Short Prior Month (K)

747

Stock Financials

EPS

-2.740

EPS Est. Current Year

-2.250

EPS Est. Next Year

-1.570

EPS Est. Next Quarter

Forward EPS

-1.575

Book Value (p.s.)

2.010

PEG Ratio

Profit Margin

Operating Margin

-3776.90

Return on Assets (ttm)

-25.9

Return on Equity (ttm)

-41.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.071

Sales Per Share

EBITDA (p.s.)

-0.875

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.20

Levered Free Cash Flow (M)

-4.81

atoplab.com

Valuation

P/E

-0.62

P/E Growth Ratio

-0.01

P/BV

0.85

P/S

406980000.00

P/CF

-2.48

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-08-01

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-05-31

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.